Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
MLYS · NASDAQ · Pharmaceutical Preparations
$13.66−0.50 (−3.53%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
Mineralys Therapeutics (MLYS) · oqro.io/stocks/MLYS · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
Planned sale · Planned for Oct 13, 2026 · Notice filed Oct 13, 2026
Officer filed to sell about $78K of MLYS stockSourceInsider trade · Traded Sep 30, 2026 · Filed Oct 2, 2026
CEO sold ~$1.91M of MLYS shares in the open marketSourceInsider trade · Traded Sep 22, 2026 · Filed Sep 25, 2026
Director sold ~$3.01M of MLYS shares in the open marketSourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Deerfield Management Company, L.P. disclosed a new position in MLYS for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Montanova Capital, LLC disclosed a reduced position in MLYS for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Orbimed Advisors LLC disclosed an increased position in MLYS for Q2 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Orbimed Advisors LLC disclosed an increased position in MLYS for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Samlyn Capital, LLC no longer reported MLYS for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Ra Capital Management, L.P. disclosed an increased position in MLYS for Q1 2026SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed May 15, 2026
Farallon Capital Management, L.L.C. disclosed a reduced position in MLYS for Q4 2025Fund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 17, 2026
Samlyn Capital, LLC disclosed a new position in MLYS for Q4 2025SourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Feb 17, 2026
Farallon Capital Management, L.L.C. disclosed a new position in MLYS for Q3 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 17, 2026
Montanova Capital, LLC disclosed a reduced position in MLYS for Q4 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 17, 2026
Orbimed Advisors LLC disclosed a reduced position in MLYS for Q4 2025Fund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 14, 2025
Ra Capital Management, L.P. disclosed an increased position in MLYS for Q3 2025SourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 14, 2025
Orbimed Advisors LLC disclosed an increased position in MLYS for Q3 2025SourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 14, 2025
Montanova Capital, LLC disclosed an increased position in MLYS for Q3 2025SourceInsider trade · Traded Sep 15, 2025 · Filed Sep 16, 2025
Officer sold ~$334K of MLYS shares in the open marketSourceInsider trade · Traded Sep 15, 2025 · Filed Sep 16, 2025
Officer sold ~$75K of MLYS shares in the open marketSourceInsider trade · Traded Sep 4, 2025 · Filed Sep 9, 2025
Director purchased ~$15M of MLYS shares in the open marketSourceInsider trade · Traded Sep 4, 2025 · Filed Sep 8, 2025
Director purchased ~$30M of MLYS shares in the open marketSourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 14, 2025
Orbimed Advisors LLC disclosed a new position in MLYS for Q2 2025SourceInsider trade · Traded Aug 13, 2025 · Filed Aug 14, 2025
Officer sold ~$147K of MLYS shares in the open marketSourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 14, 2025
Montanova Capital, LLC disclosed an increased position in MLYS for Q2 2025SourceInsider trade · Traded Jul 30, 2025 · Filed Jul 31, 2025
CFO sold ~$757K of MLYS shares in the open marketSourceInsider trade · Traded Jul 28, 2025 · Filed Jul 31, 2025
CFO sold ~$182K of MLYS shares in the open marketSourceInsider trade · Traded Jul 30, 2025 · Filed Jul 31, 2025
CFO sold ~$127K of MLYS shares in the open marketSourceInsider trade · Traded Jul 29, 2025 · Filed Jul 31, 2025
CFO sold ~$11K of MLYS shares in the open marketSourceInsider trade · Traded Jun 13, 2025 · Filed Jun 16, 2025
Officer sold ~$166K of MLYS shares in the open marketSourceFund moves · Holdings as of Mar 31, 2025 (Q1 2025) · Filed May 15, 2025
Montanova Capital, LLC disclosed a new position in MLYS for Q1 2025SourceFund moves · Holdings as of Mar 31, 2025 (Q1 2025) · Filed May 15, 2025
Ra Capital Management, L.P. disclosed an increased position in MLYS for Q1 2025SourceFund moves · Holdings as of Mar 31, 2025 (Q1 2025) · Filed May 15, 2025
Orbimed Advisors LLC no longer reported MLYS for Q1 2025SourceInsider trade · Traded May 14, 2025 · Filed May 15, 2025
Officer sold ~$174K of MLYS shares in the open marketSourceInsider trade · Traded Mar 13, 2025 · Filed Apr 25, 2025
Director purchased ~$3.5M of MLYS shares in the open marketSourceInsider trade · Traded Apr 11, 2025 · Filed Apr 16, 2025
CEO sold ~$187K of MLYS shares in the open marketSourceInsider trade · Traded Apr 11, 2025 · Filed Apr 16, 2025
CFO sold ~$130K of MLYS shares in the open marketSourceInsider trade · Traded Apr 14, 2025 · Filed Apr 16, 2025
Officer sold ~$125K of MLYS shares in the open marketSourceInsider trade · Traded Mar 13, 2025 · Filed Mar 18, 2025
10% owner purchased ~$8.1M of MLYS shares in the open marketSourceInsider trade · Traded Mar 13, 2025 · Filed Mar 18, 2025
Director purchased ~$8.1M of MLYS shares in the open marketSourceInsider trade · Traded Mar 13, 2025 · Filed Mar 17, 2025
Director purchased ~$17.5M of MLYS shares in the open marketSourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 14, 2025
Orbimed Advisors LLC disclosed a reduced position in MLYS for Q4 2024SourceInsider trade · Traded Jan 13, 2025 · Filed Jan 16, 2025
CEO sold ~$166K of MLYS shares in the open marketSourceInsider trade · Traded Jan 13, 2025 · Filed Jan 16, 2025
CFO sold ~$97K of MLYS shares in the open marketSourceInsider trade · Traded Jan 13, 2025 · Filed Jan 16, 2025
CFO sold ~$963 of MLYS shares in the open marketSourceInsider trade · Traded Nov 11, 2024 · Filed Nov 12, 2024
Officer sold ~$75K of MLYS shares in the open marketSourceInsider trade · Traded Nov 6, 2024 · Filed Nov 8, 2024
Officer sold ~$383K of MLYS shares in the open marketSourceInsider trade · Traded Oct 11, 2024 · Filed Oct 15, 2024
CEO sold ~$206K of MLYS shares in the open marketSourceInsider trade · Traded Oct 11, 2024 · Filed Oct 15, 2024
CFO sold ~$146K of MLYS shares in the open marketSourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 14, 2026
Siren, L.L.C. no longer reported MLYS for Q1 2026SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 13, 2026
Siren, L.L.C. disclosed a new position in MLYS for Q4 2025SourceInsider trade · Traded Jul 11, 2025 · Filed Jul 15, 2025
CEO sold ~$230K of MLYS shares in the open marketSourceInsider trade · Traded Jul 11, 2025 · Filed Jul 15, 2025
CFO sold ~$155K of MLYS shares in the open marketSourceInsider trade · Traded Jul 14, 2025 · Filed Jul 15, 2025
Officer sold ~$166K of MLYS shares in the open marketSourceInsider trade · Traded Apr 14, 2025 · Filed Apr 16, 2025
Officer sold ~$41K of MLYS shares in the open marketSourceInsider trade · Traded Apr 1, 2025 · Filed Apr 3, 2025
Officer sold ~$459K of MLYS shares in the open marketSourceInsider trade · Traded Apr 1, 2025 · Filed Apr 3, 2025
Officer sold ~$376K of MLYS shares in the open marketSourceInsider trade · Traded Apr 1, 2025 · Filed Apr 3, 2025
Officer sold ~$45K of MLYS shares in the open marketSource